Patents Assigned to Cell Biosciences, Inc.
  • Patent number: 8236323
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 7, 2012
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • Publication number: 20110195527
    Abstract: Methods and apparatus are provided to resolve analytes within a fluid path using isoelectric focusing, gel electrophoresis, or other separation means. Materials within the fluid path that are compatible with these separation means are used to attach resolved analytes to the wall of the fluid path. Attachment results from a triggerable event such as photoactivation, thermal activation, or chemical activation. In accordance with a further aspect of the present invention, the material in the capillary may also be disrupted, by either the triggerable event or a subsequent event such as melting or photocleavage. Thus, an open lumen or porous structure may be created within the fluid path, allowing unbound analyte materials to be washed from the fluid path, and detection agents to be washed into the fluid path. The separation-compatible materials may be polymerizable monomers, gels, entangled polymers or other materials.
    Type: Application
    Filed: April 22, 2011
    Publication date: August 11, 2011
    Applicant: Cell Biosciences, Inc.
    Inventors: Roger A. O'Neill, Marc Glazer, Tom W. Yang, Daniel J. Suich, Karl O. Voss
  • Publication number: 20110132761
    Abstract: Methods for detecting one or more analytes, such as a protein, in a fluid path are provided. The methods include resolving, immobilizing and detecting one or more analytes in a fluid path, such as a capillary. Also included are devices and kits for performing such assays.
    Type: Application
    Filed: November 19, 2010
    Publication date: June 9, 2011
    Applicant: Cell Biosciences, Inc.
    Inventors: Tom Weisan Yang, Arunashree Bhamidipati, Andrei V. Bordunov, James Eugene Knittle, Roger A. O'Neill, Karl O. Voss
  • Patent number: 7935489
    Abstract: Methods for detecting one or more analytes, such as a protein, in a fluid path are provided. The methods include resolving, immobilizing and detecting one or more analytes in a fluid path, such as a capillary. Also included are devices and kits for performing such assays.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: May 3, 2011
    Assignee: Cell Biosciences, Inc.
    Inventors: Roger A. O'Neill, Marc Glazer, Tom Weisan Yang
  • Patent number: 7935308
    Abstract: Methods for detecting one or more analytes, such as a protein, in a fluid path are provided. The methods include resolving, immobilizing and detecting one or more analytes in a fluid path, such as a capillary. Also included are devices and kits for performing such assays.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: May 3, 2011
    Assignee: Cell Biosciences, Inc.
    Inventors: Roger A. O'Neill, Marc Glazer, Tom Weisan Yang
  • Patent number: 7935479
    Abstract: Methods for detecting one or more analytes, such as a protein, in a fluid path are described herein. In some embodiments a method includes resolving one or more analytes in a fluid path, such as, for example, a capillary. After the one or more analytes are resolved, the one or more analytes are bound to the fluid path upon activation of one or more triggerable agents disposed within the fluid path. The one or more analytes that are bound to the fluid path are detected within the fluid path.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: May 3, 2011
    Assignee: Cell Biosciences, Inc.
    Inventors: Roger A. O'Neill, Marc Glazer, Tom W. Yang, Daniel J. Suich, Karl O. Voss
  • Publication number: 20110064691
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 17, 2011
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond BEARDSLEY, Anthony E. Maida, III
  • Patent number: 7846676
    Abstract: Methods for detecting one or more analytes, such as a protein, in a fluid path are provided. The methods include resolving, immobilizing and detecting one or more analytes in a fluid path, such as a capillary. Also included are devices and kits for performing such assays.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: December 7, 2010
    Assignee: Cell Biosciences, Inc.
    Inventors: Tom Weisan Yang, Arunashree Bhamidipati, Andrei V. Bordunov, James Eugene Knittle, Roger A. O'Neill, Karl O. Voss
  • Patent number: 7776818
    Abstract: T4 Immune Stimulating Factor (TISF) selectively induces aberrant T-cells to initiate apoptosis. TISF and peptides that are related to TISF (TISF peptides) are therefore useful for the treatment of disorders characterized by aberrant production, development, or activity of T-cells or other cells of hematopoietic origin. This invention relates to methods of using TISF or a TISF peptide to treat such conditions, compositions containing TISF or a TISF peptide for use in such treatments, and use of TISF or a TISF peptide for the manufacture of pharmaceuticals.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: August 17, 2010
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • Publication number: 20100144629
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Application
    Filed: February 13, 2008
    Publication date: June 10, 2010
    Applicant: S-CELL BIOSCIENCES, INC.
    Inventor: Terry Raymond Beardsley
  • Publication number: 20080267913
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: May 23, 2008
    Publication date: October 30, 2008
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida
  • Publication number: 20070190025
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: March 27, 2007
    Publication date: August 16, 2007
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Beardsley, Anthony Maida
  • Patent number: 7196060
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: March 27, 2007
    Assignee: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida, III